Please join ACG New York for our Biotech Breakfast. Our panel is comprised of experts who represent both the operating company and funding side of today’s rapidly evolving biotechnology industry. We expect to have a lively and interactive debate over the current status of biotech financing as well as what the future may have in store. Are we continuing with cyclical boom-and-bust phenomenon that has traditionally characterized the industry, or is a sea-change afoot regarding the available sources of capital and the types of companies that can successfully attract investment? We look forward to a morning of valuable discussions and productive networking.
Moderator, John Lieberman, Managing Director, Perelson Weiner LLP
Barry Kappel, Ph.D., President, CEO and Director, Sapience Therapeutics
7:30am – 8:00am – Breakfast/Networking
8:00am – 8:15am – Introductions
8:15am – 9:15am – Program followed by Q&A
9:15am – 9:30am – Additional Networking
PRICING: $85 – Member/$100 – Non-Member